Pharmacologic Management of Cognitive Disengagement Syndrome (CDS) and Implications for Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment: Emerging Treatments and Recommendations for Future Research Kelsey K. WiggsTanya E. FroehlichStephen P. Becker Leading Article 15 April 2023 Pages: 293 - 304
Idiopathic Hypersomnia: Neurobiology, Diagnosis, and Management Anne Marie MorseSreelatha Naik Review Article 18 April 2023 Pages: 305 - 322
Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy Richard K. BoganNancy Foldvary-SchaeferMichael J. Thorpy Original Research Article Open access 22 March 2023 Pages: 323 - 335
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder Matthew HarlinMurat YildirimFrank Larsen Original Research Article Open access 24 March 2023 Pages: 337 - 350
Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of Antiplatelets Roberta NosedaFederico ReaCarlo Walter Cereda Original Research Article Open access 28 March 2023 Pages: 351 - 361
Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder Simon FungMatt Shirley Adis Drug Evaluation 18 March 2023 Pages: 363 - 370